The Comparison Between HepaSphere Drug-eluting Bead Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Clinical trial NCT05862181 · UNKNOWN
Trial details
- NCT number
- NCT05862181
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-01
- Primary completion
- 2023-07-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.